The safety performance of Canada’s railways was exceptional. Compared to 2022, the total number of accidents decreased by 8.5%, the passenger train accident rate improved by 52.4%, the freight ...
The confirmatory IGNYTE-3 trial is assessing RP1 in combination with nivolumab in patients with advanced melanoma who have progressed on anti-PD-1 and anti-CTLA-4 therapies or are ineligible for ...
Numerator, a data and tech company serving the market research space, has released its rankings of Brands to Watch in 2025. The list leverages proprietary Numerator consumer data, including survey, ...